Diagnosis of pulmonary sarcoidosis

Current Opinion in Pulmonary Medicine

Volumn 19, Issue 5, 2013, Pages 510-515

  Israel Biet, Dominique ^a   Valeyre, Dominique ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

Biomarkers; EBUS transbronchial needle aspiration; Imaging; PET scan; Sarcoidosis diagnosis

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; FLUORODEOXYGLUCOSE F 18; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

COMPUTER ASSISTED TOMOGRAPHY; ENDOBRONCHIAL ULTRASONOGRAPHY; HUMAN; LUNG SARCOIDOSIS; MEDIASTINUM LYMPHADENOPATHY; POSITRON EMISSION TOMOGRAPHY; REVIEW; TRANSBRONCHIAL ASPIRATION; TRANSBRONCHIAL BIOPSY;

BIOPSY; BIOPSY, FINE-NEEDLE; ENDOSONOGRAPHY; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG; POSITRON-EMISSION TOMOGRAPHY; SARCOIDOSIS, PULMONARY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84881663492     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3283645950     Document Type: Review

References (81)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160:736-755
2. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357:2153-2165
3. Nunes H, Soler P, Valeyre D. Pulmonary sarcoidosis. Allergy 2005; 60:565-582
4. Judson MA, Thompson BW, Rabin DL, et al. The diagnostic pathway to sarcoidosis. Chest 2003; 123:406-412
5. Baughman RP, Nunes H. Therapy for sarcoidosis: Evidence-based recommendations. Expert Rev Clin Immunol 2012; 8:95-103
6. Baughman RP, Nunes H, Sweiss NJ, Lower EE. Established and experimental medical therapy of pulmonary sarcoidosis. Eur Respir J (in press
7. Drent M, Lower EE, De Vries J. Sarcoidosis-associated fatigue. Eur Respir J 2012; 40:255-263
8. Tavee J, Culver D. Sarcoidosis and small-fiber neuropathy. Curr Pain Headache Rep 2011; 15:201-206
9. Nunes H, Uzunhan Y, Gille T, et al. Imaging of sarcoidosis of the airways and lung parenchyma and correlation with lung function. Eur Respir 2012; 40:750-765
10. Grenier P, Chevret S, Beigelman C, et al. Chronic diffuse infiltrative lung disease: Determination of the diagnostic value of clinical data, chest radiography, and CT and Bayesian analysis. Radiology 1994; 191:383-390
11. Martin SG, Kronek LP, Valeyre D, et al. High-resolution computed tomography to differentiate chronic diffuse interstitial lung diseases with predominant ground-glass pattern using logical analysis of data. Eur Radiol 2010; 20; 1297-1310
12. Criado E, Sanchez M, Ramirez J, et al. Pulmonary sarcoidosis: Typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics 2010; 30:1567-1586
13. Marchiori E, Zanetti G, Escuissato DL, et al. Reversed halo sign: Highresolution CT scan findings in 79 patients. Chest 2012; 141:1260-1266
14. Marchiori E, Zanetti G, Hochhegger B, et al. Reversed halo sign on computed tomography: State-of-The-art review. Lung 2012; 190:389-394
15. Godoy MC, Viswanathan C, Marchiori E, et al. The reversed halo sign: Update and differential diagnosis. Br J Radiol 2012; 85:1226-1235
16. de Boer S, Milne DG, Zeng I, Wilsher ML. Does CT scanning predict the likelihood of a positive transbronchial biopsy in sarcoidosis? Thorax 2009; 64:436-439
17. Eckardt J, Olsen KE, Jorgensen OD, Licht PB. Minimally invasive diagnosis of sarcoidosis by EBUS when conventional diagnostics fail. Sarcoidosis Vasc Diffuse Lung Dis 2010; 27:43-48
18. Leonard C, Tormey VJ, O'Keane C, Burke CM. Bronchoscopic diagnosis of sarcoidosis. Eur Respir J 1997; 10:2722-2724
19. Trisolini R, Lazzari Agli L, Cancellieri A, et al. The value of flexible transbronchial needle aspiration in the diagnosis of stage I sarcoidosis. Chest 2003; 124:2126-2130
20. Trisolini R, Lazzari Agli L, Cancellieri A, et al. Transbronchial needle aspiration improves the diagnostic yield of bronchoscopy in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21:147-151
21. Nakajima T, Yasufuku K, Kurosu K, et al. The role of EBUS-TBNA for the diagnosis of sarcoidosis-comparisons with other bronchoscopic diagnostic modalities. Respir Med 2009; 103:1796-1800
22. Garwood S, Judson MA, Silvestri G, et al. Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis. Chest 2007; 132:1298-1304
23. Tremblay A, Stather DR, Maceachern P, et al. A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis. Chest 2009; 136:340-346
24. Tournoy KG, Bolly A, Aerts JG, et al. The value of endoscopic ultrasound after bronchoscopy to diagnose thoracic sarcoidosis. Eur Respir J 2010; 35:1329-1335
25. Herth F, Becker HD, Ernst A. Conventional vs endobronchial ultrasoundguided transbronchial needle aspiration: A randomized trial. Chest 2004; 125:322-325
26. Oki M, Saka H, Kitagawa C, et al. Prospective study of endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes versus transbronchial lung biopsy of lung tissue for diagnosis of sarcoidosis. J Thorac Cardiovasc Surg 2012; 143:1324-1329
27. Plit ML, Havryk AP, Hodgson A, et al. Rapid cytological analysis of endobronchial ultrasound-guided aspirates in sarcoidosis. Eur Respir J Express 2012
28. Navani N, Booth HL, Kocjan G, et al. Combination of endobronchial ultrasound- guided transbronchial needle aspiration with standard bronchoscopic techniques for the diagnosis of stage I and stage II pulmonary sarcoidosis. Respirology 2011; 16:467-472
29. Agarwal R, Srinivasan A, Aggarwal AN, Gupta D. Efficacy and safety of convex probe EBUS-TBNA in sarcoidosis: A systematic review and meta-analysis. Respir Med 2012; 106:883-892
30. Ernst A, Anantham D, Eberhardt R, et al. Diagnosis of mediastinal adenopathyreal- time endobronchial ultrasound guided needle aspiration versus mediastinoscopy. J Thorac Oncol 2008; 3:577-582
31. Kennedy MP, Jimenez CA, Bruzzi JF, et al. Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of lymphoma. Thorax 2008; 63:360-365
32. Wallace MB, Pascual JM, Raimondo M, et al. Minimally invasive endoscopic staging of suspected lung cancer. JAMA 2008; 299:540-546
33. Yasufuku K, Nakajima T, Fujiwara T, et al. Role of endobronchial ultrasoundguided transbronchial needle aspiration in the management of lung cancer. Gen Thorac Cardiovasc Surg 2008; 56:268-276
34. Ost DE, Ernst A, Lei X, et al. Diagnostic yield of endobronchial ultrasoundguided transbronchial needle aspiration: Results of the AQuIRE Bronchoscopy Registry. Chest 2011; 140:1557-1566
35. Eapen GA, Shah AM, Lei X, et al. Complications, consequences, and practice patterns of endobronchial ultrasound-guided transbronchial needle aspiration; results of the AQuIRE registry. Chest 2013; 140:1557-1566
36. Kennedy MP, Jimenez CA, Morice RC, et al. Factors influencing the diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration. J Bronchology Interv Pulmonol 2010; 17:202-208
37. Boujaoude Z, Dahdel M, Pratter M, Kass J. Endobronchial ultrasound with transbronchial needle aspiration in the diagnosis of bilateral hilar andmediastinal lymphadenopathy. J Bronchology Interv Pulmonol 2012; 19:19-23
38. Cetinkaya E, Ozgul MA, Tutar N, et al. The diagnostic utility of real-Time EBUSTBNA for hilar and mediastinal lymph nodes in conventional TBNA negative patients. Ann Thorac Cardiovasc Surg 2013; 1:1-7
39. Gurioli C, Ravaglia C, Romagnoli M, et al. EBUS-TBNA in mediastinal/hilar lymphadenopathies and/or masses: An Italian case series. Clin Respir J 2012; 6:3-8
40. Chee A, Khalil M, Stather DR, et al. Cytologic assessment of endobronchial ultrasound-guided transbronchial needle aspirates in sarcoidosis. J Bronchology Interv Pulmonol 2012; 19:24-28
41. Kitamura A, Takiguchi Y, Kurosu K, et al. Feasibility of cytological diagnosis of sarcoidosis with endobronchial US-guided transbronchial aspiration. Sarcoidosis Vasc Diffuse Lung Dis 2012; 29:82-89
42. Wells AU. The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease. Eur Respir Rev 2010; 19:237-241
43. Capelozzi VL, Faludi EP, Balthazar AB, et al. Bronchoalveolar lavage improves diagnostic accuracy in patients with diffuse lung disease. Diagn Cytopathol 2013; 41:1-8
44. Drent M, van Nierop MA, Gerritsen FA, et al. A computer program using BALFanalysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med 1996; 153:736-741
45. Drent M, Jacobs JA, Cobben NA, et al. Computer program supporting the diagnostic accuracy of cellular BALF analysis: A new release. Respir Med 2001; 95:781-786
46. Winterbauer RH, Lammert J, Selland M, et al. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest 1993; 104:352-361
47. Drent M, Mansour K, Linssen C. Bronchoalveolar lavage in sarcoidosis. Semin Respir Crit Care Med 2007; 28:486-495
48. Meyer KC, Raghu G, Baughman RP, et al. An official American Thoracic Society clinical practice guideline: The clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 2012; 185:1004-1014
49. Danila E, Norkuniene J, Jurgauskiene L, Malickaite R. Diagnostic role of BAL fluid CD4/CD8 ratio in different radiographic and clinical forms of pulmonary sarcoidosis. Clin Respir J 2009; 3:214-221
50. Kantrow SP, Meyer KC, Kidd P, Raghu G. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J 1997; 10:2716-2721
51. Kolopp-Sarda MN, Kohler C, De March AK, et al. Discriminative immunophenotype of bronchoalveolar lavage CD4 lymphocytes in sarcoidosis. Lab Invest 2000; 80:1065-1069
52. Heron M, van Lochem EG, Hooijkaas H, et al. Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis. Clin Immunol 2008; 126:338-344
53. Mota PC, Morais A, Palmares C, et al. Diagnostic value of CD103 expression in bronchoalveolar lymphocytes in sarcoidosis. Respir Med 2012; 106; 1014-1020
54. Hyldgaard C, Kaae S, Hiddervold M, et al. Value of s-ACE, BAL lymphocytosis, and CD4/CD8and CD103CD4/CD4T-cell ratios in diagnosis of sarcoidosis. Eur Respir J 2012; 39:1037-1039
55. Basu S, Saboury B, Werner T, Alavi A. Clinical utility of FDG-PET and PET/CT in nonmalignant thoracic disorders. Mol Imaging Biol 2011; 13:1051-1060
56. Treglia G, Taralli S, Giordano A. Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: A systematic review. Sarcoidosis Vasc Diffuse Lung Dis 2011; 28:87-94
57. Keijsers RG, van den Heuvel DA, Grutters JC. Imaging the inflammatory activity of sarcoidosis. Eur Respir J 2013; 41:743-751
58. Keijsers RG, Grutters JC, Thomeer M, et al. Imaging the inflammatory activity of sarcoidosis: Sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET. Q J Nucl Med Mol Imaging 2011; 55; 66-71
59. Mostard RL, Verschakelen JA, van Kroonenburgh MJ, et al. Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis. Respir Med 2013; 107:439-447
60. Mostard RL, Van Kuijk SM, Verschakelen JA, et al. A predictive tool for an effective use of (18)F-FDG PET in assessing activity of sarcoidosis. BMC Pulm Med 2012; 12:57
61. Sobic-Saranovic D, Grozdic I, Videnovic-Ivanov J, et al. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis. J Nucl Med 2012; 53:1543-1549
62. Keijsers RG, Verzijlbergen EJ, van den Bosch JM, et al. 18F-FDG PET as a predictor of pulmonary function in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2011; 28:123-129
63. Teirstein AS, Machac J, Almeida O, et al. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 2007; 132:1949-1953
64. Braun JJ, Kessler R, Constantinesco A, Imperiale A. 18F-FDG PET/CT in sarcoidosis management: Review and report of 20 cases. Eur J Nucl Med Mol Imaging 2008; 35:1537-1543
65. Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 2006; 47:1571-1576
66. Gayet AR, Plaisance P, Bergmann JF, Mouly S. Development of sarcoidosis following completion of treatment for hepatitis C with pegylated interferon- {alpha}2a and ribavirin: A case report and literature review. Clin Med Res 2010; 8:163-167
67. Gitlin N. Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: A report of two cases. Eur J Gastroenterol Hepatol 2002; 14:883-885
68. Tong D, Manolios N, Howe G, Spencer D. New onset sarcoid-like granulomatosis developing during anti-TNF therapy: An under-recognised complication. Intern Med J 2012; 42:89-94
69. Daien CI, Monnier A, Claudepierre P, et al. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford) 2009; 48:883-886
70. Ramos-Casals M, Perez-Alvarez R, Perez-de-Lis M, et al. Pulmonary disorders induced by monoclonal antibodies in patients with rheumatologic autoimmune diseases. Am J Med 2011; 124:386-394
71. Shigemitsu H. Is sarcoidosis frequent in patients with cancer? Curr Opin Pulm Med 2008; 14:478-480
72. Kennedy MP, Jimenez CA, Mhatre AD, et al. Clinical implications of granulomatous inflammation detected by endobronchial ultrasound transbronchial needle aspiration in patients with suspected cancer recurrence in the mediastinum. J Cardiothorac Surg 2008; 3:8
73. Hunt BM, Vallieres E, Buduhan G, et al. Sarcoidosis as a benign cause of lymphadenopathy in cancer patients. Am J Surg 2009; 197:629-632; discussion 632
74. Chowdhury FU, Sheerin F, Bradley KM, Gleeson FV. Sarcoid-like reaction to malignancy on whole-body integrated (18)F-FDG PET/CT: Prevalence and disease pattern. Clin Radiol 2009; 64:675-681
75. Butt S, Alzebdeh R, Kable TD, Soubani AO. Noncaseating granulomas in patients after the diagnosis of cancer: Clinical characteristics and outcome. Sarcoidosis Vasc Diffuse Lung Dis 2011; 28:44-49
76. Jain V, Hasselquist S, Delaney MD. PET scanning in sarcoidosis. Ann N Y Acad Sci 2012; 1228:46-58
77. Zhao S, Kuge Y, Kohanawa M, et al. Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: A comparison with 18F-FDG and 18F-FLT. J Nucl Med 2008; 49:135-141
78. Kaira K, Oriuchi N, Otani Y, et al. Diagnostic usefulness of fluorine-18-alphamethyltyrosine positron emission tomography in combination with 18Ffluorodeoxyglucose in sarcoidosis patients. Chest 2007; 131:1019-1027
79. Thillai M, Eberhardt C, Lewin AM, et al. Sarcoidosis and tuberculosis cytokine profiles: Indistinguishable in bronchoalveolar lavage but different in blood. PLoS One 2012; 7:e38083
80. Maertzdorf J, Weiner J 3rd, Mollenkopf HJ, et al. Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc Natl Acad Sci U S A 2012; 109:7853-7858
81. Li QH, Li HP, Shen YP, et al. A novel multiparameter scoring system for distinguishing sarcoidosis from sputum negative tuberculosis. Sarcoidosis Vasc Diffuse Lung Dis 2012; 29:11-18